Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation

Fig. 5

Comparison of the expression levels of immunomodulatory drug clinical trial targets in cervical cancer between two groups. A The expression levels of PD1, PD-L1 and PD-L2 between two groups. B The expression levels of CTLA-4, CD80 and CD86 between two groups. C The expression levels of LAG3, TIM3 and TIGIT between two groups. D The expression levels of OX40, GITR, 4-1BB, ICOS, CD40 CD27 and CD70 between two groups

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us